|
Variant ID: 125 |
cDNA Change | c.1391delC |
|---|---|---|
| Amino Acid Change | p.Pro464Hisfs*32 (Legacy AA No. 404) | |
| Type | Deletion | |
| Effect | Frameshift | |
| Domain | Serine Protease | |
| Sequence Context | delC | |
| Location | Exon( 9) | |
| Minor Allele Frequency (MAF) |
The details of the cases reported with the above variant is as below
| Case ID | Other Variants found in case | Genotype | FVII:C (%) | FVII:Ag (%) | Reported Clinical Severity | Reference | Comments | ||
|---|---|---|---|---|---|---|---|---|---|
| TF-Unknown | TF-Human | TF-Rabbit | |||||||
| 153 | 8 | Heterozygous | 2 | mild | Giansily-Blaizot et al 2001 | Female | |||
| 155 | 7 | Heterozygous | 4 | 48 | mild | Giansily-Blaizot et al 2001 | |||
| 379 | 3 | Heterozygous | <1 | <1 | severe | Carew et al 1998 | |||
| 213 | 9 | Heterozygous | 08-Dec | unknown | Wulff et al 2000 | ||||
| 10 | 9 | Heterozygous | 14-40 | asymptomatic | Wulff et al 2000 | ||||
| 169 | 9 | Heterozygous | 1 | 1 | mild | Wulff et al 2000 | |||
| 225 | 8 | Heterozygous | <1 | severe | Giansily-Blaizot et al 2001 | ||||
| 292 | 9 | Heterozygous | 15 | severe | Wulff et al 2000 | ||||
| 168 | 9 | Heterozygous | <1 | 10 | unknown | Wulff et al 2000 | |||
| 87 | 8 | Homozygous | <1 | <1 | unknown | Wulff et al 2000 | |||
| 114 | 3 | Homozygous | 3 | 4 | 17 | moderate | Arbini et al 1994 | ||
| 58 | 3 | Homozygous | <2 | <2 | 2 | moderate | Arbini et al 1994 | ||
| 59 | 3 | Homozygous | <2 | <2 | 3 | moderate | Arbini et al 1994 | ||
| 60 | 3 | Homozygous | <2 | <2 | 3 | moderate | Arbini et al 1994 | ||
| 103 | 3 | Homozygous | <2 | <2 | 3 | severe | Arbini et al 1994 | ||
| 104 | 3 | Homozygous | <2 | <2 | 1 | moderate | Arbini et al 1994 | ||
| 105 | 3 | Homozygous | <2 | <2 | 1 | moderate | Arbini et al 1994 | ||
| 108 | 3 | Homozygous | <2 | <2 | 4 | moderate | Arbini et al 1994 | ||
| 110 | 3 | Homozygous | <2 | <2 | 2 | moderate | Arbini et al 1994 | ||
| 111 | 3 | Heterozygous | 40 | 44 | 45 | asymptomatic | Arbini et al 1994 | ||
| 112 | 3 | Heterozygous | 52 | 44 | 43 | mild | Arbini et al 1994 | ||
| 113 | 3 | Heterozygous | 38 | 27 | 34 | asymptomatic | Arbini et al 1994 | ||
| 115 | 3 | Heterozygous | 40 | 36 | 42 | asymptomatic | Arbini et al 1994 | ||
| 116 | 3 | Heterozygous | 60 | 62 | 56 | asymptomatic | Arbini et al 1994 | ||
| 117 | 3 | Homozygous | 4 | 4 | 12 | moderate | Arbini et al 1994 | ||
| 489 | 3 | Heterozygous | 15 | UK | Moderate | Herrmann et al 2000 | |||
| 490 | 3 | Heterozygous | 1.3 | 0.9 | Mild | Herrmann et al 2000 | |||
| 493 | 3 | Heterozygous | <1 | UK | Mild | Herrmann et al 2000 | |||
| 497 | 3 | Heterozygous | 5 | UK | Moderate | Herrmann et al 2000 | |||
| 499 | 3 | Heterozygous | 10 | UK | Mild | Herrmann et al 2000 | |||
| 501 | 3 | Heterozygous | 10 | UK | Mild | Herrmann et al 2000 | |||
| 545 | 2 | Homozygous | 1 | UK | Mild | Herrmann et al 2009 | |||
| 546 | 2 | Homozygous | UK | UK | Severe | Herrmann et al 2009 | |||
| 547 | 2 | Homozygous | UK | UK | Asymptomatic | Herrmann et al 2009 | |||
| 548 | 2 | Homozygous | UK | UK | Asymptomatic | Herrmann et al 2009 | |||
| 549 | 2 | Homozygous | UK | UK | Asymptomatic | Herrmann et al 2009 | |||
| 550 | 2 | Homozygous | UK | UK | Asymptomatic | Herrmann et al 2009 | |||
| 551 | 2 | Homozygous | 0_<2 | 0_<2 | Severe | Herrmann et al 2009 | |||
| 552 | 2 | Homozygous | 0_<2 | 0_<2 | Severe | Herrmann et al 2009 | |||
| 553 | 2 | Homozygous | 0_<2 | 0_<2 | Severe | Herrmann et al 2009 | |||
| 554 | 2 | Homozygous | 0_<2 | 0_<2 | Herrmann et al 2009 | thrombotic episode | |||
| 555 | 2 | Homozygous | 0_<2 | 0_<2 | Herrmann et al 2009 | thrombotic episode | |||
| 556 | 2 | Homozygous | 0_<2 | 0_<2 | Herrmann et al 2009 | thrombotic episode | |||
| 557 | 2 | Homozygous | 0_<2 | 0_<2 | Moderate | Herrmann et al 2009 | |||
| 558 | 2 | Homozygous | 0_<2 | 0_<2 | Moderate | Herrmann et al 2009 | |||
| 559 | 2 | Homozygous | 0_<2 | 0_<2 | Moderate | Herrmann et al 2009 | |||
| 560 | 2 | Homozygous | 0_<2 | 0_<2 | Moderate | Herrmann et al 2009 | |||
| 561 | 2 | Homozygous | 0_<2 | 0_<2 | Moderate | Herrmann et al 2009 | |||
| 567 | 3 | Heterozygous | 1 | UK | Severe | Herrmann et al 2009 | |||
| 572 | 3 | Heterozygous | 1 | UK | Severe | Herrmann et al 2009 | |||
| 573 | 3 | Heterozygous | 3 | UK | Severe | Herrmann et al 2009 | |||
| 575 | 3 | Heterozygous | 8 | UK | Severe | Herrmann et al 2009 | |||
| 578 | 3 | Heterozygous | 2 | UK | Severe | Herrmann et al 2009 | |||
| 581 | 3 | Heterozygous | 17 | UK | Severe | Herrmann et al 2009 | |||
| 582 | 2 | Heterozygous | <1 | UK | Severe | Herrmann et al 2009 | |||
| 717 | 2 | Homozygous | <1 | 1 | Moderate | Fromovich-Amit et al 2004 | |||
| 746 | 2 | Homozygous | 1.2 | 2.6 | Mariani et al 2003 | Haemorrhages and Thrombosis | |||
| 747 | 2 | Homozygous | 0.8 | 2 | Mariani et al 2003 | Haemorrhages and Thrombosis | |||
| 505 | 3 | Heterozygous | <1 | <1 | Mild | Herrmann et al 2000 | |||